IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2023 Holdings

Filed 2023-05-16 | 12 holdings | $49.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$49.2M177,12699.4%
Regeneron Pharmaceuticals(REGN)COM75886F107$48.9K59,4880.1%
United Therapeutics Corp(UTHR)COM91307C102$45.3K202,1100.1%
Exelixis Inc(EXEL)COM30161Q104$41.5K2,135,8680.1%
Alkermes PLC(ALKS)COMG01767105$39.3K1,395,7970.1%
Embecta Corp(EMBC)COM29082K105$29.9K1,062,1230.1%
Cardinal Health Inc(CAH)COM14149Y108$26.7K353,2780.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$24.4K603,3010.0%
Taro Pharmaceutical IndusCOMM8737E108$15.6K641,9100.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$3.2K113,7370.0%
Kodiak Sciences Inc(KOD)COM50015M109$2.8K459,4890.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$2.5K361,5600.0%